content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001600946</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001053369</issuerCik>
        <issuerName>ELITE PHARMACEUTICALS INC /NV/</issuerName>
        <secFileNumber>001-15697</secFileNumber>
        <issuerAddress>
          <com:street1>165 LUDLOW AVENUE</com:street1>
          <com:city>NORTHVALE</com:city>
          <com:stateOrCountry>NJ</com:stateOrCountry>
          <com:zipCode>07647</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>2017502646</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Plassche Douglas</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Officer</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Fidelity Brokerage Services LLC</name>
          <address>
            <com:street1>245 Summer Street</com:street1>
            <com:city>Boston</com:city>
            <com:stateOrCountry>MA</com:stateOrCountry>
            <com:zipCode>02110</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>500000</noOfUnitsSold>
        <aggregateMarketValue>303000.00</aggregateMarketValue>
        <noOfUnitsOutstanding>1068463108</noOfUnitsOutstanding>
        <approxSaleDate>07/08/2025</approxSaleDate>
        <securitiesExchangeName>Other</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock </securitiesClassTitle>
        <acquiredDate>07/03/2025</acquiredDate>
        <natureOfAcquisitionTransaction>Stock Options Exercise </natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>ELTP</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>2500000</amountOfSecuritiesAcquired>
        <paymentDate>07/01/2025</paymentDate>
        <natureOfPayment>cash/check</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>07/08/2025</noticeDate>
        <signature>/s/ Audrey Skillern as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Douglas PLASSCHE</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2849}]
text: 144
  0001600946
  XXXXXXXX
  LIVE
  0001053369
  ELITE PHARMACEUTICALS INC /NV/
  001-15697
  165 LUDLOW AVENUE
  NORTHVALE
  NJ
  07647
  2017502646
  Plassche Douglas
  Officer
  Common
  Fidelity Brokerage Services LLC
  245 Summer Street
  Boston
  MA
  02110
  500000
  303000.00
  1068463108
  07/08/2025
  Other
  Common Stock
  07/03/2025
  Stock Options Exercise
  ELTP
  N
  2500000
  07/01/2025
  cash/check
  Y
  07/08/2025
  /s/ Audrey Skillern as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Douglas PLASSCHE